---
created: 2025-04-13
updated: 2025-04-13T10:53
id: e#LzOu8$dA
specialty: cardio
specialty_id: 337
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/firstaid::07-cardiovascular::05-pharm::01-hypertension-treatment
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::09-cardiac
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::10-cardiac::01-hypertension-treatment
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::02-cardio-&-renal::fa-cardio
  - "source/ak-step1-v11:": 
  - theme/uworld::100-999::100-199::151
  - "source/ak-step1-v11:": 
  - theme/uworld::10000-99999::15000-15999::15239
  - source/ak-step1-v11::^other::^expn::bgadd
  - source/ak-step1-v11::^other::^fa-updates::fa2018
  - source/ak-step1-v11::^other::^highyield::3-highyield-temporary
  - source/ak-step1-v11::^systems::cardio::pharmacology"
type: flashcard
---

# Question
In patients with hypertension and what comorbidity should ACE inhibitors / ARBs become first line?    **Hypertension with Diabetes Mellitus**

---

# Answer
ACE-i/ARBs are protective against diabetic nephropathy; Ca2+ channel blockers, thiazides, and Î²-blockers are good to use here as well